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Abstract
Recent studies have shown a genetic influence on gene expression variation, chromatin, and DNA methylation. However,
the effects of genetic background and tissue types on DNA methylation at the genome-wide level have not been
characterized extensively. To study the effect of genetic background and tissue types on global DNA methylation, we
performed DNA methylation analysis using the Affymetrix 500K SNP array on tumor, adjacent normal tissue, and blood DNA
from 30 patients with esophageal squamous cell carcinoma (ESCC). The use of multiple tissues from 30 individuals allowed
us to evaluate variation of DNA methylation states across tissues and individuals. Our results demonstrate that blood and
esophageal tissues shared similar DNA methylation patterns within the same individual, suggesting an influence of genetic
background on DNA methylation. Furthermore, we showed that tissue types are important contributors of DNA methylation
states.
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Introduction
Epigenetic information is contained within DNA and protein
components of chromatin; the former is represented mainly by 5-
methylcytosine modification of DNA [1], whereas the latter has
more complex constituents consisting of histone and non-histone
proteins as well as their post-translational modifications [2]. Gene
expression patterns are established and maintained by epigenetic
information in the chromatin during the development of an
organism. Epigenetic plasticity provides the mechanism for tissue
differentiation and physiological response to the changing environ-
ment; abnormal regulation of epigenetic information is involved in
many human diseases including cancer. Epigenetic alterations are
hallmarks of human cancer (for reviews see [3,4]). Global DNA
hypomethylation was first observed in human cancer nearly 25
years ago [5,6]. Subsequently, increased DNA methylation in the
promoter region was found to be a common mechanism by which
tumor suppressor genes are inactivated in human cancer [7,8,9].
The hypermethyation often occurred in CpG islands near the
transcription start site (TSS) of the inactivated genes. The
annotation of CpG islands for the entire human genome is available
in public databases such as the NCBI and UCSC databases. In
addition to altered DNA methylation, an array of histone post-
translational modifications is often abnormal in human cancer, and
proteins responsible for modifying chromatin are similarly altered
[10,11,12]. Recently, epigenetic investigation has shifted to the
genome-wide scale using high throughput technology, and a
number of methods have been developed to study DNA
methylation at this level. [13,14,15,16,17].
The DNA methylation state in blood, tumor, and adjacent
normal tissue can provide an insight into epigenetic mechanisms
that contribute to carcinogenesis [18,19,20,21]. DNA methylation
patterns from white blood cells (designated as ‘‘blood’’) can
potentially be used to diagnose cancer early, assess prognosis, and
monitor response to chemotherapy and radiation therapy. We
previously demonstrated that genetic background influenced
global epigenetic states characterized by histone H3 lysine 9/14
acetylation and lysine 4/9/27 methylation [22]. A recent paper
reported that DNA sequences determine allele-specific DNA
methylation [23]. A longitudinal family-based study indicated that
global DNA methylation changed over time and displayed familial
clustering [24]. Furthermore, a comparison of MZ (monozygotic)
and DZ (dizygotic) twins showed that DNA methylation
differences in the buccal cells of DZ twins were higher than those
of MZ twins [25], suggesting that heritability may include DNA
methylation in addition to DNA sequences.
Esophageal squamous cell carcinoma (ESCC) is one of the most
common malignancies in China. Incidence rates of ESCC vary
widely in different geographic regions. Shanxi Province in north
central China is a region that has a very high esophageal cancer
rate. Within high-risk regions, there is a strong tendency toward
familial aggregation, suggesting that genetic susceptibility, in
conjunction with environmental exposures, plays a role in the
etiology of ESCC [26,27]. Previously, we identified several
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number (CN) alterations in ESCC using microsatellite markers
and the Affymetrix 10K SNP array [28,29]. More recently we
mapped many genomic regions that showed copy number gain or
loss, thus paving the way for identifying oncogenes and tumor
suppressor genes in the future [30]. Despite progress in the
genomic analysis of ESCC, we know little about global DNA
methylation level in normal or tumor cells in esophageal tissue. In
this study, we set out to characterize global DNA methylation in
three different tissues, blood, normal, and ESCC, from 30
individuals. We found that both genetic background and tissue
types impact global DNA methylation.
Results and Discussion
Our study design had three samples in each set; the samples
consisted of DNA from blood, tumor, and adjacent normal tissue
from the same individual. We analyzed 90 samples (30 sets, 3
samples in each set). Global DNA methylation was determined
using methylation-sensitive Hpa II digestion followed by hybrid-
ization to Affymetrix 500K SNP arrays [31]. Because our goal was
to assess methylation in a quantitative manner, it was necessary to
factor the underlying variation inherent in the DNA among tested
individuals into the methylation score. Conventional genotyping
without Hpa II digestion on the 90 samples supplied the baseline
DNA variation information. To evaluate the quality of genotype
experiments, we compared genotype calls that were generated
using the Affymetrix Gtype 4.0 software between blood and
normal experiments. The genotype call rates generally exceeded
99% for blood and normal esophageal DNA, and the concor-
dances between the genotype calls of the two tissues were in the
range of 98.8%–99.8%, demonstrating high quality of the
genotype data. For quantitative evaluation of DNA methylation
data, we applied a method that we previously developed to analyze
chromatin immunoprecipitation (ChIP) data generated using the
Affymetrix SNP array experiments [22]. This method is briefly
summarized in the Materials and Methods section.
To explore the variation of DNA methylation patterns in relation
to tissue types and genetic background, we performed principal
components analysis (PCA) to visualize DNA methylation patterns
among samples in reduced dimension space (see Materials and
Methods for details about PCA analysis). We projected the samples
using the first two principal components (PC1 and PC2). Each
principal component (PC) is a linear combination of DNA
methylation scores measured from SNPs across the whole genome
with certain attributes. The Sty I Affymetrix SNP chip contains
238,304 SNPs. Of these SNPs, 62,765 were contained within
Affymetrix probes homologous to regions in the sample DNA with
the attributes required for our methylation analysis: (1) the Sty I
fragmenthasatleastoneHpaIIsite;(2)the SNPwithinthefragment
does not overlap an Hpa II site; and (3) the SNP is located on an
autosome. The results of PCA using data from these 62,765 SNPs
are shown in Figure 1A (note: a similar result was observed using the
data from the Nsp I chip). In this study PC1 and PC2 provided an
efficient way to visualize relationships among the samples in two-
dimension space. Two sample clusters were evident, which
corresponded to the blood and normal samples, supporting the idea
that DNA methylation is dependent on tissue types. Although PC1
and PC2 captured only 24% of the total variation, they grasped the
biological variation due to different tissues and different individuals.
Analyses involving additional principal components didn’t yield any
new insight into the nature of DNA methylation.
A unique feature of our study design was the comparison of
DNA methylation among multiple tissues from a single individual.
Of particular interest was the comparison of DNA methylation in
blood versus normal tissue. We wanted to know whether DNA
methylation from blood and esophageal tissues from the same
individual shared a similar pattern. This central question addresses
the potential role of genetics in determining tissue methylation
[22,23,25,32]. In the graph shown in Figure 1A, we noted that
blood and normal esophageal samples from a single individual had
similar scores in PC1 (paired samples are connected by dotted lines
in Figure 1A), indicating that these two samples from an individual
had a similar DNA methylation level as measured by the PC1
score. To illustrate that the two tissues from the same individual
had similar PC1 scores, we generated a plot using a unit length
arrow that emanated from the normal sample and pointed to the
paired blood sample in the direction corresponding the line shown
in Figure 1A for each individual (Figure 1B). These arrows clearly
point in the same direction, indicating similar PC1 scores for the
paired samples from the same individual. Our data showed a
greater similarity in methylation between the two tissues from a
single individual, as demonstrated by similar methylation in PC1
score. One interpretation of this result is that genetic background
can influence DNA methylation, as we have also previously
demonstrated at the level of chromatin modifications [22]. To
evaluate whether DNA sequences alone could explain this pattern
of PCA, we also performed similar analyses using the measure-
ments of genomic DNA from the genotyping experiments (Sty
experiment without Hpa II digestion). PCA was also performed
using quantitative values of the hybridization signals [22] rather
than the conventional interpretative approach, i.e. using genotyp-
ing calls generated according to a calling algorithm. Comparing
the results from DNA methylation and genomic DNA, we found
two important differences: (i) The clusters in the projection of
genomic DNA were not well separated (Figure 1C); and (ii) The
arrows in Figure 1D and Figure 2D were more randomly
distributed than those in Figure 1B and Figure 2B. In the DNA
analysis, blood and normal esophageal samples from a single
individual produced very different scores in PC1 (Figure 1C and
1D). Thus, the similarities of PC1 scores in DNA methylation from
two different tissues of a single individual are specific. To
understand the distribution of the arrows, we generated an angle
plot (Figure S1). The angles are more uniform and have smaller
standard deviations in the methylation data than the DNA data
(Figure S1A and Figure S1B, also see Table S1). We conclude that
global DNA methylation is affected by the genetic background.
The two clusters of samples correspond to the two tissue types
(Figure 1A), indicating that tissue type is an important determinant
of DNA methylation.
To further characterize the relationship among different
individuals and tissues, we performed pair wise correlation
analyses and displayed the results of methylation in Figure 3A
and DNA in Figure 3B. The results from these analyses support
our interpretation of PCA. Specifically, correlations between 3
tissues are apparent in Figure 3B (DNA) revealed by the 3 yellow
diagonal lines. The correlations between blood and tumor samples
are least because the presence of genomic instability in tumors and
some cross-contamination between normal and tumor samples.
Correlations in methylation analyses are generally less compared
to the DNA analysis. However, the 3 yellow diagonal lines remain,
suggesting that DNA methylation is similar among different tissues
from the same individual. The main conclusion that genetic
background influences methylation is supported by correlation
analysis.
We extended the DNA methylation analysis to include tumors
from the same individuals. As shown in Figure 2A, three clusters
are evident, which correspond to the blood, normal, and tumor
Global DNA Methylation
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Furthermore, all three tissues from the same individual shared
similar DNA methyation angle signature, as demonstrated by a
similar direction of the arrows shown in Figure 2B (green arrows
point from normal to blood; red arrows point from tumor to
blood). As a control, PCA projection using data from DNA
analysis showed random distribution of samples (Figure 2C and
2D). Similarly, the angle plots showed narrower distribution and
smaller standard deviation from methylation data than DNA data
(Figure S1c vs. Figure S1d and Figure S1e vs. Figure S1f, also see
Table S1). Thus, global DNA methylation angle signatures in
different tissues, including both normal and tumor tissues, are
similar in the same individual, indicating a strong influence of
genetic background on DNA methylation.
To further analyze genetic influence on DNA methylation, the
differences between blood and normal tissue for the same
Figure 1. Analysis of DNA methylation patterns in blood and esophageal tissue from 30 ESCC patients. Figure 1A shows the PCA using
methylation measurements. Two clusters are evident, corresponding to blood and normal samples. Samples are labeled with blue (patient blood,
letter B) and green (patient normal, letter N). The numbers indicate patients. Blood and normal samples from a single patient are connected by a
dashed line. The dashed lines are mostly parallel to PC2 axis due to nearly identical PC1 scores between blood and normal esophageal tissue from a
single individual. Figure 1B shows unit length direction arrows of the same data as Figure 1A. An arrow emanates from a normal sample and points to
blood. The direction of the arrow is identical to that of the dashed line in Figure 1A. Figure 1C shows similar PCA using quantitative DNA
measurements. Data processing and analysis is similar to Figure 1A. The DNA measurements serve as a control for variation in the samples. Figure 1D
shows the plot of arrows using the data from Figure 1C. It is evident that the arrows in Figure 1D (for DNA) are randomly orientated due to different
PC1 scores between the two tissues from the same single individual.
doi:10.1371/journal.pone.0009355.g001
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selected SNP-marked fragments within the indicated genes. Each
circle represents the difference in methylation measurements
between blood and normal tissue (blue, from the same individual,
labeled as Hpa2.paired; red, from two different individuals,
labeled as Hpa2.unpaired) or the difference in DNA analysis
(green, from the same individual labeled as gDNA.paired; pink,
from two different individuals, labeled as gDNA.unpaired). The
absolute difference in methylation is smaller in the two tissues from
the same individual in these graphs (blue circles, labeled as
Hpa2.paired) than in the two tissues from two different individuals
(red circles, labeled as Hpa2.unpaired). To understand the overall
distribution of the quantitative effect of genetic influence on DNA
methylation across SNPs, we applied the Ansari-Bradley two-
sample test, a non-parametric method, to compare the scale
parameters for two sets of differences between blood and normal
assays: the first set contains 30 differences with one for each
individual; the second set contains 870 differences with one for
each pair of two different individuals. The method tests the ratio of
the scales for the two sets of the differences. The alternative
Figure 2. Analysis of DNA methylation patterns in blood, normal esophageal tissue, and tumors. The analysis is similar to Figure 1
except that we include 30 tumors from the same individuals. Figure 2A shows the PCA using methylation measurements. Three clusters are evident,
corresponding to blood, normal, and tumor samples. Samples are labeled with blue (patient blood, letter B), green (patient normal, letter N), and red
(patient tumor, letter T). Figure 2B shows unit length direction arrows of the same data as Figure 2A. The green arrows emanate from normal and
point to blood samples whereas the red arrows start from tumors and point to blood samples. Figure 2C shows similar PCA using quantitative DNA
measurements. Data processing and analysis is similar to Figure 2A. The DNA measurements serve as a control for variation in the samples. Figure 2D
shows the plot of arrows using the data from Figure 2C. It is evident that the arrows in Figure 2D (for DNA) are randomly orientated due to different
PC1 and PC2 scores between different tissues from a single individual.
doi:10.1371/journal.pone.0009355.g002
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PLoS ONE | www.plosone.org 4 February 2010 | Volume 5 | Issue 2 | e9355Figure 3. Heat map displays pair wise correlation results for methylation and genomic DNA data. Figure 3A contains methylation data.
We have 90 microarray data generated from samples consisting of 3 tissues (blood, normal, and ESCC) from 30 individuals. All pair wise comparisons
were analyzed, and Pearson correlation coefficients were plotted in the heat map. Figure 3B has genomic DNA data. Analyses are similar to Figure 3A
except for the use of quantitative values from the genotype experiments.
doi:10.1371/journal.pone.0009355.g003
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PLoS ONE | www.plosone.org 5 February 2010 | Volume 5 | Issue 2 | e9355Figure 4. Analyses of DNA methylation difference between blood and normal esophageal tissue for single individuals. Figure 4A
displays the genes that exhibit similar methylation measurements between blood and normal esophageal tissue for single individuals relative to the
differences between blood and normal tissue for different individuals. Each circle represents a comparison of: (1) methylation measurements
between blood and normal tissue (blue from the same individual labeled as Hpa2.paired, 30 data points per gene; red from two different individuals
labeled as Hpa2.unpaired, 870 data points) or (2) DNA analysis (green from the same individual labeled as gDNA.paired, 30 data points; pink from two
different individuals labeled as gDNA.unpaired, 870 data points). These calculations were carried out for the genes indicated on the x-axis. The SNPs
marking the individual genes are rs7203335 (SNX29), rs8190404 (DIA1), rs12780199 (INPP5A), rs3760220 (DKFZP586L0724), rs3768723 (PIGF),
rs7605146 (DNAPTP6), rs11254 (ETS2), rs6464151 (PRKAG2), rs2302592 (TTLL5), and rs1265074 (CCHCR1). Figure 4B shows the histogram of p-values
in the Ansari-Bradley two-sample test for methylation (red bars, labeled with Hpa2) and DNA (green bars, labeled with gDNA) measurements. For
each SNP, the ratio of scales was tested for two samples: one is the methylation differences between blood and normal tissue from 30 pairs of
individuals and another is the methylation differences between the two tissues from two different individuals from the 870 pairs resulting from
selecting 2 out 30 individuals in all combinations. As a control, we performed similar analyses using data from DNA array experiments. The histogram
summarizes the distribution of the negative log10pvalues from the analyses of the methylation and DNA data.
doi:10.1371/journal.pone.0009355.g004
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paired differences is less than the scale for unpaired differences. As
a control, we performed similar analyses using data from DNA
measurements. The ratio of the scales is significantly less than one
for many of the tested SNPs (Figure 4B, red bars, labeled as Hpa2,
indicate methylation data), showing greater similarity of methyl-
ation in two different tissues from the same individual. Some SNPs
also showed smaller p-values for DNA measurements (Figure 4B,
green bars, labeled as gDNA), reflecting DNA differences in the
genetic background of different individuals. Nevertheless, the
distribution is clearly shifted to the right (smaller p-value,
indicating a smaller ratio of the scales) for the methylation data
(Figure 4B, red bars). A non-parametric method was used instead
of an F-test because the Shapiro-Wilk normality test showed that
the differences were not normal for 65% of SNPs in the
methylation data and 70% of SNPs in the genomic DNA data.
In conclusion, we found that DNA methylation characteristics
in normal esophageal tissue and blood from the same individual
were remarkably similar. Our results indicate that genetic
background as well as tissue environment can influence global
DNA methyation patterns. This conclusion is consistent with
previous studies that showed genetic background affected global
chromatin modifications [22,23,24,25,32].
Materials and Methods
Patient Selection
The study was approved by the Institutional Review Boards of
the Shanxi Cancer Hospital and the U.S National Cancer Institute
(NCI). Written informed consents were obtained for all partici-
pants of this study. Patients diagnosed with ESCC between 1998
and 2001 in the Shanxi Cancer Hospital in Taiyuan, Shanxi
Province, People’s Republic of China, and considered candidates
for curative surgical resection were identified and recruited to
participate in this study. None of the patients had prior therapy
and Shanxi was the ancestral home for all.
DNA Isolation
Venous blood (10 ml) was taken from each patient prior to
surgery and germ-line DNA from whole blood was extracted and
purified using the standard phenol/chloroform method. Tumor
and adjacent normal tissues were dissected at the time of surgery
and stored in liquid nitrogen until use. One 5-micron section was
H&E stained and reviewed by a pathologist from NCI as the guide
for micro-dissection. Five to ten consecutive 8-micron sections
were cut from fresh frozen tumor tissues. Tumor cells were
manually micro-dissected under light microscope visualization.
DNA was extracted from micro-dissected tumor as previously
described [29] using the protocol from Puregene DNA Purification
Tissue Kit (Gentra Systems, Inc., Minneapolis, MN).
Microarray Experiment
We performed genotyping and methylation experiments using
the Affymetrix Mapping 500K array set (Nsp I array and Sty I
array). The detailed protocol for genotyping can be found at
http://www.affymetrix.com/support/downloads/manuals/500k_
assay_manual.pdf. Methylation experiments were carried out
essentially in the same manner as conventional genotyping assays
except for pre-digestion of genomic DNA with Hpa II restriction as
described [31]. http://www.affymetrix.com/support/technical/
manual/expression_manual.affx
The Gene Expression Omnibus (GEO) accession number for
these array data is GSE20123.
Data Analysis
All statistical analyses were developed using R packages. The
analytic method to extract quantitative values from methylation
and genotyping experiments was essentially identical to our
previous published work [22]. Briefly, the probe level measure-
ments were generated using Affymetrix Gtype software. Micro-
array data were normalized using a modified RMA method [22].
We used the probe level measurements from standard genotyping
experiments that contained 144 case-control blood DNA samples
as a reference set to normalize the data. After the normalization
process, we obtained measurements at the probeset level for all
microarray data, for both DNA and methylation. The correlation
data used in the analyses described in this manuscript are included
in Table S2 and Table S3.
We used principal component analysis (PCA) to analyze
variation among the samples for DNA methylation and genotype
data. The PCA method transforms the raw data into a more
interpretable form. The raw data are generated as a matrix, in
which each column represents one sample and each row, one
probeset. The probeset is specific for methylation or genomic
signal, depending on the laboratory assay. The PCA method
works by rotating this system of matrix coordinates (i.e. probesets
or SNPs) in such way that a new set of variables are generated;
these new variables are called the ‘‘principal components’’. A
principal component is actually a linear combination of the
original variables, each of which is weighted by a different
coefficient. The weight represented in each coefficient reflects the
degree of contribution that the corresponding SNP makes to the
principal component. The resulting principal components are
ordered, i.e. numbered, so that PC1 accounts for the largest
variance in the data and is followed by PC2, PC3, etc. PC1 and
PC2 are the only principal components that are displayed in our 2-
dimensional analysis. A major value of the PCA method is
reduction in the number of dimensions inherent in the huge
amount of microarray data. This allows visualization of the data in
two dimensions.
To analyze methylation differences between blood and normal,
we compared paired (2 tissues from a single individual) versus
unpaired methylation measurements (2 tissues from different
individuals). For each SNP, the Ansari-Bradley two-sample test
was applied to the comparison in the scale of 30 paired differences
and the scale of 870 unpaired differences. As a control, the same
test was conducted for DNA measurements. To compare the p-
values from the Ansari-Bradley tests for methylation with those for
DNA, we included only those SNPs for which paired scale was
significantly less than the unpaired scale at the p-value level of 0.05
for either methylation or genomic DNA or both.
Supporting Information
Figure S1 Angle plot of blood, normal, and tumor samples
based on methylation measurements by principal component
analysis (PCA). Plots are labeled with green (normal) and red
(tumor). The angle plots in Figures S1a and S1b were generated
from PCA projects in Figures 1b and 1d. The angle plots in
Figures S1c and S1d were generated from PCA projects in
Figures 2b and 2d, and contain the arrows from normal to blood.
The angle plots in Figures S1e and S1f were also generated from
PCA projects in Figures 2b and 2d, but contain the arrows from
tumor to blood.
Found at: doi:10.1371/journal.pone.0009355.s001 (0.01 MB
PDF)
Table S1 Statistical analysis of data in Figure S1. B, N and T
are abbreviations for blood, normal and tumor samples. B-N-T
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first column of the table. The variances of the angles in the
methylation data are significantly smaller than those in the DNA
data based on the F-test.
Found at: doi:10.1371/journal.pone.0009355.s002 (0.02 MB
XLS)
Table S2 Correlation coefficients for methylation experiments.
Data are described in Results and Discussion as well as Materials
and Methods.
Found at: doi:10.1371/journal.pone.0009355.s003 (0.16 MB
XLS)
Table S3 Correlation coefficients for DNA experiments. Data
are described in Results and Discussion as well as Materials and
Methods.
Found at: doi:10.1371/journal.pone.0009355.s004 (0.16 MB
XLS)
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